Search form

Home
LoginSubscribe
  • Home
  • Country Intelligence
  • Industry Directory
  • Offsets / IC
  • Tenders
    • Haiti(0/week)
    • Guyana(0/week)
    • Honduras(0/week)
    • Jamaica(0/week)
    • Netherlands Antilles(0/week)
      • View all (0/week)
  • News
    • United States(1133/week)
    • Manufacturing(603/week)
    • Technology(1091/week)
    • Energy(452/week)
    • Other Manufacturing(400/week)
  • Events
  • About us
    • Who we are
    • Our People
    • Partners
    • Contact us
  • LinkedIn
  • Login
  • Twitter
  • Register
  • Home
  • News

GV20 Therapeutics

Jun 02, 2025
GV20 Therapeutics Presents Updated Phase 1 Monotherapy Data on GV20-0251 at the ASCO Annual Meeting 2025
May 23, 2025
GV20 Therapeutics to Present Updated Phase 1 Monotherapy Data on GV20-0251 at the ASCO Annual Meeting 2025
Mar 26, 2025
GV20 Therapeutics Announces Collaboration Agreement with Mitsubishi Tanabe Pharma Corporation to Develop Novel Antibody-Drug Conjugates
Sep 16, 2024
GV20 Therapeutics Presents Promising Phase 1 Monotherapy Data on Novel Checkpoint Inhibitor GV20-0251 at ESMO Congress 2024
Aug 21, 2024
GV20 Therapeutics to Present Clinical Data on GV20-0251 at the ESMO Congress 2024
Apr 24, 2024
GV20 Therapeutics Announces Publication in Cell Highlighting the Discovery of IGSF8 as an Innate Immune Checkpoint and Cancer Immunotherapy Target
Apr 18, 2024
GV20 Therapeutics Announces Clinical Trial Collaboration to Evaluate GV20-0251, a First-in-Class Antagonist Antibody Against the Novel Immune Checkpoint IGSF8, in Combination with KEYTRUDA® (pembrolizumab)
Apr 08, 2024
GV20 Therapeutics Presents Preclinical Data on GV20-0251 for Solid Tumors Targeting IGSF8 at AACR Annual Meeting 2024
Apr 02, 2024
GV20 Therapeutics to Present at the Needham 23rd Annual Virtual Healthcare Conference
Mar 12, 2024
GV20 Therapeutics Joins NVIDIA Inception to Develop AI Models for Drug and Target Discovery
Mar 05, 2024
GV20 Therapeutics Announces Oral Presentation on GV20-0251 for Solid Tumors Targeting IGSF8 at AACR Annual Meeting 2024

Latest News

Jul 30, 2025

dynaCERT Appoints John Amodeo as Director, Expanding Global Sales Strategy

Jul 30, 2025

Faraday Future to Present at the J.P. Morgan Auto Investor Conference in New York on August 12, 2025

Jul 30, 2025

QinetiQ US Secures $26 Million in Naval Defense Contracts with General Dynamics Electric Boat for Next-...

Jul 30, 2025

Northrop Grumman Tests Sentinel Missile Stage-Two Rocket Motor

Jul 30, 2025

Lockheed Martin Delivers 250th MK 48 Guidance and Control Section

Jul 30, 2025

RTX's Raytheon introduces advanced targeting system for U.S. Navy helicopters

Jul 30, 2025

Compass Minerals Announces Conference Call to Discuss Third-Quarter Fiscal 2025 Results

Jul 30, 2025

Delek Logistics Partners, LP Increases Quarterly Cash Distribution to $1.115 per Common Limited Partner Unit

View all News

Agenda

30
September
PortugalTroia, Portugal
Seabed Security, 30 September - 01 October 2025, Troia, Portugal
Seabed Security | 30 September - 01 October 2025 | Troia, Portugal Defence iQ Announces Inaugural Seabed Security...
23
September
United KingdomLondon, UK
Countering Explosive Threat & Demining conference, September 23 - 24, 2025, London, UK
Countering Explosive Threat & Demining conference | September 23 - 24, 2025 | London, UK The Countering Explosive...
View All Events

SUBSCRIBE

to Epicos.com
Please register in order to have access to personalized daily information on world-wide A&D industry developments and business opportunities.
Subscribe

REGISTER

for Epicos.com Newsletter
Sign up for our free newsletters and receive twice a week news and intelligence regarding the Aerospace & Defence Industry, meticulously selected by our editorial team.
Sign Up
Home
  • SIGN UP FOR NEWSLETTER
  • NEWSLETTER ARCHIVE
  • ADVERTISE WITH US
  • CONTACT US
  • PRIVACY POLICY
  • INFORMATION SECURITY POLICY
© 2025 EPICOS
Made by Wedia